Handelsavisen
prelaunch
Companies ›Consumer Non Cyclicals ›300858.SZ
30
300858.SZ — Shenzhen Stock Exchange Food Processing

Beijing Scitop Bio-tech Co Ltd

¥17,36
Open in Charts → Attach watcher ⌖
— —
CNY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
4,6B CNY
P/E
—
EV / Rev
—
Div yield
0,84 %
Op margin
28,6 %
ROE
5,1 %
Net margin
25,8 %
Debt / equity
0,00
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About

Beijing Scitop Bio-tech Co Ltd is a food processing company that generates revenue through the production and sale of food products.

Business. Beijing Scitop Bio-tech Co Ltd (300858.SZ) is a food processing company headquartered in Beijing, China. The firm operates within the Food & Beverages industry, focusing on the production and sale of food products. It is primarily listed on the Shenzhen Stock Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.

Classification92 %
SectorConsumer Non-Cyclicals
Business sectorFood & Beverages
IndustryFood Processing
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
Upcoming events
— missing data
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership
—
not yet wired
Profitability→
5,1 %
return on equity
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 300858.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 300858.SZ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Beijing Scitop Bio-tech Co Ltd (300858.SZ) is a food processing company headquartered in Beijing, China. The firm operates within the Food & Beverages industry, focusing on the production and sale of food products. It is primarily listed on the Shenzhen Stock Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.

    Classification92 %
    SectorConsumer Non-Cyclicals
    Business sectorFood & Beverages
    IndustryFood Processing
    AI synthesis
    GENERATED

    The company's capital structure is characterized by a high proportion of equity, with total equity of 1,842,828,090 CNY and total liabilities of 176,080,810 CNY, resulting in a debt-to-equity ratio of 0.0. The liquidity position is mixed, with a current ratio of 7.66 indicating strong short-term liquidity, but a negative net cash position after subtracting total debt. The price-to-book ratio of 2.41 and price-to-tangible-book ratio of 2.41 suggest the market is valuing the company at a premium to its book value.

    Profitability metrics show a return on equity of 5.13% and a return on assets of 4.68%, which are below the industry median for the Food Processing sector. The gross profit margin is 51.43% (188,198,030 CNY / 365,922,710 CNY), and the operating margin is 28.59% (104,585,750 CNY / 365,922,710 CNY), both of which are strong but not necessarily indicative of superior performance relative to the industry. The net income margin is 25.83% (94,519,400 CNY / 365,922,710 CNY), which is also robust.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of segment and geographic diversification could expose the company to higher operational and market risks.

    The company's growth trajectory is not clearly defined in the provided data, as there are no forward-looking revenue projections or historical growth rates available. The free cash flow is negative at -207,408,560 CNY, and capital expenditures are -296,122,800 CNY, indicating significant reinvestment in the business. The price-to-earnings ratio of 47.06 and enterprise value-to-revenue ratio of 12.16 suggest the company is currently trading at a premium relative to its earnings and revenue.

    The risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests potential liquidity constraints. The company has not disclosed any dilution sources in the provided data, and the dilution potential is low.

    There are no recent events or filings disclosed in the provided data that would significantly impact the company's operations or financial position.

    Key takeaways
    • The company has a strong equity position and a high current ratio, but a negative net cash position raises liquidity concerns.
    • Profitability metrics are robust but not necessarily superior to industry medians.
    • The company's revenue is concentrated in a single business segment with no disclosed geographic diversification.
    • The company is trading at a premium to both book value and earnings.
    • The company has a low dilution risk but a medium liquidity risk.
    • There is no recent event data to assess near-term operational or financial risks.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    ¥17,36
    Market cap
    ¥4.45B
    Enterprise valueⓘ
    ¥4.45B
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    36.1x
    P / Bⓘ
    2.4x
    P / Tangible bookⓘ
    2.4x
    Tangible book
    ¥1.84B
    Net cashⓘ
    -¥3.6M
    Current ratioⓘ
    7.7
    Debt / equityⓘ
    0.0
    ROAⓘ
    4.7%
    ROEⓘ
    5.1%
    Cash conversionⓘ
    131.0%
    CapEx / revenueⓘ
    -80.9%
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin28,6 %Best in class
    Net Margin25,8 %Best in class
    ROE5,1 %Above median
    Capex / Rev-80,9 %Bottom quartile
    D/E0,00Above P75
    Cash Conv1,31Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    Source documents
    • Beijing Scitop Bio-tech Co Ltd Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    300858.SZCanonical
    Shenzhen Stock Exchange · CNY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage